HP: Priced Too Low With A High Yield
seekingalpha.com
Cerus CorporationCERSNASDAQ
LOADING
|||
Alerts
Want to monitor CERS?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor CERSWant to monitor CERS?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor CERScerus corporation is a biomedical products company focused on commercializing the intercept blood system to enhance blood safety. the intercept system is designed to reduce the risk of transfusion-transmitted diseases by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. the nucleic acid targeting mechanism of action enables intercept treatment to inactivate established transfusion threats, such as hepatitis b and c, hiv, west nile virus and bacteria, and is designed to inactivate emerging pathogens such as influenza, malaria and dengue.